The main health threat in developing states today is not plagues or parasites but illnesses such as cancer and diabetes, noncommunicable diseases long associated with the rich world.

Thomas J. Bollyky discusses President Obama's nomination of Jim Yong Kim to lead the World Bank.

In an era of global supply chains, the United States should pursue regulatory integration on a regional basis. A new White House initiative provides the opportunity to implement this strategy.

The main health threat in developing states today is not plagues or parasites but illnesses such as cancer and diabetes, noncommunicable diseases long associated with the rich world.

Thomas Bollyky assesses President Obama's record in promoting international science in the latest issue of Science. The president has made strides in integrating science into U.S. diplomacy and international development activities, but only modest progress on facilitating the day-to-day scientific exchanges that account for most international research.

Thomas Bollyky examines strategies to improve access to neglected disease treatments and sustainably meet the treatment needs of the world's poorest people.

Thomas J. Bollyky discusses tobacco's reemergence as a polarizing issue in U.S. trade policy.

Climate change has both direct and indirect health consequences. Direct consequences include those resulting from high temperatures and severe weather events; while indirect ones arise from changing air and water quality and ecological shifts that favor tropical diseases and parasites.

Read full answer

A comprehensive new study of the world's health status has the potential to dramatically improve how developing countries address surging problems like noncommunicable diseases, writes CFR's Thomas Bollyky.

The World Health Assembly in Geneva this week needs to do more to define a workable mission for the struggling World Health Organization.

The 2011 high-level UN meeting on non-communicable diseases fell far short of the major funding and targets agreed to at a similar meeting on HIV/AIDS a decade ago, which CFR's Thomas Bollyky says indicates a need for different actors and approaches on chronic diseases.

One year after the UN's high-level meeting on noncommunicable diseases, little progress has been made in generating momentum and new resources. But with the right focus and strategies, there is room to move forward, says CFR's Thomas Bollyky.

Despite not delivering major mandates, the summit could start a new process for sustainable development and open opportunities for new stakeholders, says CFR's Thomas Bollyky.

Thomas Bollyky discusses the brewing fight over intellectual property and access to noncommunicable disease medicines in low- and middle-income countries and a potential way forward.

Thomas Bollyky writes about how national patent laws are affecting pharmaceutical cost differentials around the world.

Thomas J. Bollyky discusses President Obama's nomination of Jim Yong Kim to lead the World Bank.

CFR Senior Fellow Thomas J. Bollyky contributes to this volume the chapter "Regulatory Coherence in the TPP Talks."

CFR Senior Fellow Thomas J. Bollyky discusses the rise of noncommunicable diseases in low- and middle-income countries, the United Nations' efforts to address this rapidly emerging health problem, and paths for collective action.

As tobacco use proliferates in the developing world, an innovative incentive mechanism could supplement tobacco control efforts in low- and middle-income countries.

As tobacco reemerges as a contentious issue in trade policy, CFR Senior Fellow Thomas Bollyky argues that the Obama administration can better balance U.S. mandates on tobacco trade policy with its interests in promoting global health and U.S. standing abroad.

CFR Senior Fellow Thomas Bollyky argues that new strategies are needed to address the latest treatment-access crisis over patented medications, particularly as noncommunicable diseases continue to rapidly emerge in low- and middle-income countries.

In an era of global supply chains, the United States should pursue regulatory integration on a regional basis. A new White House initiative provides the opportunity to implement this strategy.

The winner of the 2012 presidential election faces an important leadership test on trade, which will have challenges and opportunities, says CFR's Thomas Bollyky, including leveling the playing field with China and finalizing the Trans-Pacific Partnership.